Condition
Perimembranous Ventricular Septal Defect
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Not Yet Recruiting1
Unknown1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04034498Active Not RecruitingPrimary
A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects
NCT06823635Not Yet RecruitingPrimary
An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
NCT02644330Phase 2UnknownPrimary
Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect
Showing all 3 trials